Drug Shortage Report for SANDOZ AMBRISENTAN TABLETS
| Report ID | 218454 |
| Drug Identification Number | 02526883 |
| Brand name | SANDOZ AMBRISENTAN TABLETS |
| Common or Proper name | AMBRISENTAN TABLETS |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | AMBRISENTAN |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 10MG 30FCT |
| ATC code | C02KX |
| ATC description | OTHER ANTIHYPERTENSIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-02-05 |
| Estimated end date | 2024-04-19 |
| Actual end date | 2024-04-23 |
| Shortage status | Resolved |
| Updated date | 2024-04-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2024-04-24 | English | Compare |
| v17 | 2024-04-23 | French | Compare |
| v16 | 2024-04-23 | English | Compare |
| v15 | 2024-04-16 | French | Compare |
| v14 | 2024-04-16 | English | Compare |
| v13 | 2024-04-02 | French | Compare |
| v12 | 2024-04-02 | English | Compare |
| v11 | 2024-03-18 | French | Compare |
| v10 | 2024-03-18 | English | Compare |
| v9 | 2024-03-05 | French | Compare |
| v8 | 2024-03-05 | English | Compare |
| v7 | 2024-02-19 | French | Compare |
| v6 | 2024-02-19 | English | Compare |
| v5 | 2024-02-12 | French | Compare |
| v4 | 2024-02-12 | English | Compare |
| v3 | 2024-02-06 | English | Compare |
| v2 | 2024-02-05 | French | Compare |
| v1 | 2024-02-05 | English | Compare |
Showing 1 to 18 of 18